Most anticancer drugs have their origin in traditional medicinal plants. We describe here a flavone, 5,3Ј-dihydroxy-3,6,7,8,4Ј-pentamethoxyflavone (PMF), from the leaves of the Thai plant Gardenia obtusifolia, that has anti-inflammatory and anticancer potential. Because the nuclear factor-B (NF-B) pathway is linked to inflammation and tumorigenesis, we investigated the effect of PMF on this pathway. We found that PMF suppressed NF-B activation induced by inflammatory agents, tumor promoters, and carcinogens. This suppression was not specific to the cell type. Although PMF did not directly modify the ability of NF-〉 proteins to bind to DNA, it inhibited IB␣ (inhibitory subunit of NF-B) kinase, leading to suppression of phosphorylation and degradation of IB␣, and suppressed consequent p65 nuclear translocation, thus abrogating NF-B-dependent reporter gene expression.Suppression of the NF-B cell signaling pathway by the flavone led to the inhibition of expression of NF-B-regulated gene products that mediate inflammation (cyclooxygenase-2), survival (XIAP, survivin, Bcl-xL, and cFLIP), proliferation (cyclin D1), invasion (matrix metalloproteinase-9), and angiogenesis (vascular endothelial growth factor). Suppression of antiapoptotic gene products by PMF correlated with the enhancement of apoptosis induced by tumor necrosis factor-␣ and the chemotherapeutic agents cisplatin, paclitaxel, and 5-flurouracil. Overall, our results indicate that PMF suppresses the activation of NF-B and NF-B-regulated gene expression, leading to the enhancement of apoptosis. This is the first report to demonstrate that this novel flavone has anti-inflammatory and anticancer effects by targeting the IKK complex.